Correlation Between Exicure and Zivo Bioscience
Can any of the company-specific risk be diversified away by investing in both Exicure and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exicure and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exicure and Zivo Bioscience, you can compare the effects of market volatilities on Exicure and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exicure with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exicure and Zivo Bioscience.
Diversification Opportunities for Exicure and Zivo Bioscience
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Exicure and Zivo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Exicure and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Exicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exicure are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Exicure i.e., Exicure and Zivo Bioscience go up and down completely randomly.
Pair Corralation between Exicure and Zivo Bioscience
If you would invest 1,615 in Exicure on December 28, 2024 and sell it today you would lose (216.00) from holding Exicure or give up 13.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Exicure vs. Zivo Bioscience
Performance |
Timeline |
Exicure |
Zivo Bioscience |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Exicure and Zivo Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exicure and Zivo Bioscience
The main advantage of trading using opposite Exicure and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exicure position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.Exicure vs. Ikena Oncology | Exicure vs. HCW Biologics | Exicure vs. RenovoRx | Exicure vs. Tempest Therapeutics |
Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |